Biolase Inc
BIOL
Market Cap$4.86M
Close$
$1.53
920.2% upside
Current Fair Value
920.2% upsideUndervalued by 920.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.86 Million |
|---|---|
| Enterprise Value | $12.34 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-29.44 |
| Beta | 0.81 |
| Outstanding Shares | 32,522,593 |
| Avg 30 Day Volume | 10,995,992 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.13 |
|---|---|
| PEG | -0.1 |
| Price to Sales | 0.15 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.25 |
| Enterprise Value to EBIT | -0.69 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.14 |
| Debt to Equity | 7.18 |
Revenue Sources
No data
ESG Score
No data
About Biolase Inc
CEO: Todd Norbe